Jump to ContentJump to Main Navigation
Show Summary Details

Biological Chemistry

Editor-in-Chief: Brüne, Bernhard

Editorial Board Member: Buchner, Johannes / Lei, Ming / Ludwig, Stephan / Sies, Helmut / Turk, Boris / Wittinghofer, Alfred


SCImago Journal Rank (SJR) 2015: 1.607
Source Normalized Impact per Paper (SNIP) 2015: 0.751
Impact per Publication (IPP) 2015: 2.609

249,00 € / $374.00 / £187.00*

Online
ISSN
1437-4315
See all formats and pricing

 


 
 

Select Volume and Issue
Loading journal volume and issue information...

30,00 € / $42.00 / £23.00

Get Access to Full Text

The Role of Heterotrimeric G Proteins in Platelet Activation

S. Offermanns

Citation Information: Biological Chemistry. Volume 381, Issue 5-6, Pages 389–396, ISSN (Print) 1431-6730, DOI: 10.1515/BC.2000.051, July 2005

Publication History

Published Online:
2005-07-05

Abstract

Activation of platelets plays a central role in hemostasis as well as in various thromboembolic diseases like myocardial infarction or stroke. Most platelet activating stimuli function through receptors which couple to heterotrimeric G proteins of the Gi, Gq and G12 families. Recent studies have elucidated the roles of individual G proteins in the regulation of platelet functions like shape change, aggregation and granule secretion. The signaling pathways mediated by heterotrimeric G proteins operate synergistically to induce a full activation of platelets. This review summarizes recent progress in the understanding of upstream regulation of platelet activation through G protein-coupled receptors.

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

[2]
Gilberto R. Sambrano, Ethan J. Weiss, Yao-Wu Zheng, Wei Huang, and Shaun R. Coughlin
Nature, 2001, Volume 413, Number 6851, Page 74
[3]
Bhanu Kanth Manne, Rachit Badolia, Carol A. Dangelmaier, and Satya P. Kunapuli
Biochemical Pharmacology, 2015, Volume 93, Number 2, Page 163
[4]
T. M. Getz, B. K. Manne, L. Buitrago, Y. Mao, and S. P. Kunapuli
Thrombosis and Haemostasis, 2013, Volume 109, Number 6, Page 1131
[5]
J. L. Gu, S. Muller, V. Mancino, S. Offermanns, and M. I. Simon
Proceedings of the National Academy of Sciences, 2002, Volume 99, Number 14, Page 9352
[6]
Hans-Michael Jantzen, David S. Milstone, Laurent Gousset, Pamela B. Conley, and Richard M. Mortensen
Journal of Clinical Investigation, 2001, Volume 108, Number 3, Page 477
[7]
A. MCNICOL, A. AGPALZA, E. C. G. JACKSON, H. HAMZEH-COGNASSE, O. GARRAUD, and F. COGNASSE
Journal of Thrombosis and Haemostasis, 2011, Volume 9, Number 10, Page 2038
[8]
Ulrike R. Schwarz, Ulrich Walter, and Martin Eigenthaler
Biochemical Pharmacology, 2001, Volume 62, Number 9, Page 1153
[9]
V. Gupta, A. Roy, and B. C. Tripathy
Plant and Cell Physiology, 2010, Volume 51, Number 10, Page 1788
[10]
Jie Zhang, Yong Zhang, Shao-Gui Wan, Shuang-Shuang Wei, Wen-Hui Lee, and Yun Zhang
Biochemical and Biophysical Research Communications, 2005, Volume 330, Number 4, Page 1027
[11]
Alexander Zarbock, Renata K. Polanowska-Grabowska, and Klaus Ley
Blood Reviews, 2007, Volume 21, Number 2, Page 99
[12]
Nina Wettschureck, Alexandra Moers, and Stefan Offermanns
Pharmacology & Therapeutics, 2004, Volume 101, Number 1, Page 75
[13]
Toshio Uemura, Tomihisa Kawasaki, Masatoshi Taniguchi, Yumiko Moritani, Kazumi Hayashi, Tetsu Saito, Jun Takasaki, Wataru Uchida, and Keiji Miyata
British Journal of Pharmacology, 2009, Volume 148, Number 1, Page 61
[14]
S. S. Ahmad, F. S. London, and P. N. Walsh
Journal of Thrombosis and Haemostasis, 2003, Volume 1, Number 1, Page 48
[15]
G. JALAGADUGULA, D. N. DHANASEKARAN, S. KIM, S. P. KUNAPULI, and A. K. RAO
Journal of Thrombosis and Haemostasis, 2006, Volume 4, Number 12, Page 2678
[16]
S. Jones, K. L. Tucker, T. Sage, W. J. Kaiser, N. E. Barrett, P. J. Lowry, A. Zimmer, S. P. Hunt, M. Emerson, and J. M. Gibbins
Blood, 2008, Volume 111, Number 2, Page 605
[17]
Jörg Geiger
Expert Opinion on Investigational Drugs, 2001, Volume 10, Number 5, Page 865
[18]
B. Nieswandt, M. Moser, I. Pleines, D. Varga-Szabo, S. Monkley, D. Critchley, and R. Fassler
Journal of Experimental Medicine, 2007, Volume 204, Number 13, Page 3113
[19]
Hans-Michael Jantzen, David S. Milstone, Laurent Gousset, Pamela B. Conley, and Richard M. Mortensen
Journal of Clinical Investigation, 2001, Volume 108, Number 3, Page 477
[20]
Lakiea Bailey, Yuichi Kuroyanagi, Carla F. Franco-Penteado, Nicola Conran, Fernando F. Costa, Sabrina Ausenda, Maria D. Cappellini, and Tohru Ikuta
British Journal of Haematology, 2007, Volume 138, Number 3, Page 382
[21]
Makoto Yoshida, Yukari Sato, Tokuro Shimura, Satoko Ohkubo, Shigeyoshi Honma, Takao Tanaka, Tadashi Kurimoto, and Norimichi Nakahata
Pharmacology, 2007, Volume 79, Number 1, Page 50
[22]
B. NIESWANDT, B. AKTAS, A. MOERS, and U.J.H. SACHS
Journal of Thrombosis and Haemostasis, 2005, Volume 3, Number 8, Page 1725
[23]
R. T. Dorsam, M. Tuluc, and S. P. Kunapuli
Journal of Thrombosis and Haemostasis, 2004, Volume 2, Number 5, Page 804

Comments (0)

Please log in or register to comment.